BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15015041)

  • 1. Structural study of copper(I)-bleomycin.
    Lehmann TE
    J Biol Inorg Chem; 2004 Apr; 9(3):323-34. PubMed ID: 15015041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination chemistry of co(II)-bleomycin: its investigation through NMR and molecular dynamics.
    Lehmann TE; Serrano ML; Que L
    Biochemistry; 2000 Apr; 39(14):3886-98. PubMed ID: 10747776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of the three-dimensional structure of Fe(II)-bleomycin: are the Co(II) and Fe(II) adducts isostructural?
    Lehmann TE
    J Biol Inorg Chem; 2002 Mar; 7(3):305-12. PubMed ID: 11935354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR studies of the paramagnetic complex Fe(II)-bleomycin.
    Lehmann TE; Ming LJ; Rosen ME; Que L
    Biochemistry; 1997 Mar; 36(10):2807-16. PubMed ID: 9062108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of Fe(II)-azide-bleomycin derived from NMR data: transition from Fe(II)-bleomycin to Fe(II)-azide-bleomycin as derived from NMR data and structural calculations.
    Lehmann T; Li Y
    J Biol Inorg Chem; 2012 Jun; 17(5):761-71. PubMed ID: 22481631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axial ligation of Fe(II)-bleomycin probed by XANES spectroscopy.
    Smolentsev G; Soldatov AV; Wasinger EC; Solomon EI
    Inorg Chem; 2004 Mar; 43(6):1825-7. PubMed ID: 15018497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the solution structure of the bleomycin-A2-zinc complex by means of two-dimensional NMR spectroscopy and distance geometry calculations.
    Akkerman MA; Haasnoot CA; Hilbers CW
    Eur J Biochem; 1988 Apr; 173(1):211-25. PubMed ID: 2451607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible structural role of the disaccharide unit in Fe-bleomycin before and after oxygen activation.
    Lehmann TE; Li Y
    J Antibiot (Tokyo); 2012 Jan; 65(1):25-33. PubMed ID: 22068157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of HO(2)-Co(III)bleomycin A(2) bound to d(GAGCTC)(2) and d(GGAAGCTTCC)(2): structure-reactivity relationships of Co and Fe bleomycins.
    Zhao C; Xia C; Mao Q; Försterling H; DeRose E; Antholine WE; Subczynski WK; Petering DH
    J Inorg Biochem; 2002 Jul; 91(1):259-68. PubMed ID: 12121784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordination chemistry and solution structure of Fe(II)-peplomycin. Two possible coordination geometries.
    Li Y; Lehmann T
    J Inorg Biochem; 2012 Jun; 111():50-8. PubMed ID: 22484500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper(I)-bleomycin: structurally unique complex that mediates oxidative DNA strand scission.
    Ehrenfeld GM; Rodriguez LO; Hecht SM; Chang C; Basus VJ; Oppenheimer NJ
    Biochemistry; 1985 Jan; 24(1):81-92. PubMed ID: 2581602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR determination of the structures of peroxycobalt(III) bleomycin and cobalt(III) bleomycin, products of the aerobic oxidation of cobalt(II) bleomycin by dioxygen.
    Xu RX; Nettesheim D; Otvos JD; Petering DH
    Biochemistry; 1994 Feb; 33(4):907-16. PubMed ID: 7508261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative binding properties of metallobleomycins with DNA 10-mers.
    Li W; Zhao C; Xia C; Antholine WE; Petering DH
    Biochemistry; 2001 Jun; 40(25):7559-68. PubMed ID: 11412110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of Ru-bleomycin complexes by resonance Raman, circular dichroism, and NMR spectroscopy.
    Mouzopoulou B; Kozlowski H; Katsaros N; Garnier-Suillerot A
    Inorg Chem; 2001 Dec; 40(27):6923-9. PubMed ID: 11754273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage.
    Hoehn ST; Junker HD; Bunt RC; Turner CJ; Stubbe J
    Biochemistry; 2001 May; 40(20):5894-905. PubMed ID: 11352724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metal bonding domain of the antitumor drug Fe(II)-bleomycin: a DFT investigation.
    Karawajczyk A; Buda F
    J Biol Inorg Chem; 2005 Jan; 10(1):33-40. PubMed ID: 15578242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR studies on Cu(II)-peptide complexes: exchange kinetics and determination of structures in solution.
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Mol Biosyst; 2005 May; 1(1):79-84. PubMed ID: 16880967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The solution structure of the Ga(III)-bleomycin A2 complex resolved by NMR and molecular modeling; interaction with d(CCAGGCCTGG).
    Papakyriakou A; Mouzopoulou B; Katsaros N
    J Biol Inorg Chem; 2003 May; 8(5):549-559. PubMed ID: 12632272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of copper-bleomycin complexes: evidence of a three-step process.
    Albertini JP; Garnier-Suillerot A
    J Inorg Biochem; 1985 Sep; 25(1):15-24. PubMed ID: 2413168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper(I) . bleomycin. A structurally unique oxidation-reduction active complex.
    Oppenheimer NJ; Chang C; Rodriguez LO; Hecht SM
    J Biol Chem; 1981 Feb; 256(4):1514-7. PubMed ID: 6161924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.